Skip to main content

Pancrelipase News

Pancreatic Enzyme Therapy Linked to Drop in Pediatric Acute Pancreatitis

TUESDAY, April 16, 2024 – Use of pancreatic enzyme therapy (PERT) is associated with a reduction in the incidence rate of acute pancreatitis (AP) among children with pancreatic sufficient acute...

Digestive Care, Inc. Announces FDA Approval of Pertzye (pancrelipase) Delayed-Release Capsules

BETHLEHEM, Pa., May 18, 2012 /PRNewswire/ – Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for...

Aptalis Pharma Announces FDA Approval of Viokace (Pancrelipase) Tablets

BRIDGEWATER, NJ--(Marketwire - March 1, 2012) - Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, announced that the U.S. Food and...

Aptalis Pharma Announces FDA Approval of Ultresa (Pancrelipase) Delayed Release Capsules

BRIDGEWATER, NJ--(Marketwire - March 1, 2012) - Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis, announced that the U.S. Food and...

FDA Approves Pancreatic Enzyme Product, Pancreaze

SILVER SPRING, Md., April 12 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Pancreaze Delayed Release Capsules, a pancreatic enzyme product (PEP). It is the third...

Eurand Granted FDA Approval for Zenpep

PHILADELPHIA, PA, Aug 28, 2009 – Eurand N.V., a specialty pharmaceutical company, today announced U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for Zenpep...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Pancreatitis, Cystic Fibrosis

Related drug support groups

Creon

Pancrelipase patient information at Drugs.com